Hiroyuki Yasui
Kyoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroyuki Yasui.
Journal of Pharmacokinetics and Biopharmaceutics | 1991
Yoshitaka Yano; Kiyoshi Yamaoka; Hiroyuki Yasui; Terumichi Nakagawa
An arterial and venous blood (or plasma) concentration difference of drugs across the lung of rats was evaluated based on the recirculatory concept. The recirculatory system is given by the combination of the transfer functions for the pulmonary and the systemic circulations and is described by a Laplace-transformed equation, i.e., an image equation. For the manipulation of the image equations, the fast inverse Laplace transform (FILT) was adopted and MULTI(FILT) was used for the simultaneous curve fitting to estimate the pharmacokinetic parameters in the recirculatory model. Metoprolol as a test drug and cephalexin as a control drag were infused, respectively into the femoral vein for 30 min, and arterial and venous blood samples were collected simultaneously through the cannula at the femoral artery and at right atrium during and after the infusion. Exponential functions were assumed for the weight functions through both the pulmonary and systemic circulations. Results of the curve fitting showed that the single-pass extraction ratio through the pulmonary circulation (Ep)of meloprolol was about 0.2, whereas that of cephalexin was negligible. The mean transit times through the pulmonary circulation (¯tpof metoprolol and cephalexin were both about 0.5 min, which is small. The singlepass extraction ratios through the systemic circulation (Es)of metoprolol and cephalexin were both about 0.1. and the mean transit times through the systemic circulation (¯tswere 11.5 min and 8.2 min, respectively.
Journal of Pharmacokinetics and Biopharmaceutics | 1995
Hiroyuki Yasui; Kiyoshi Yamaoka; Terumichi Nakagawa
AbstractA new hepatocellular diffusion model was developed to kinetically evaluate the hepatobiliary transport processes of drugs in the perfusion system, based on the physiological structure of the liver. Since the equations describing the hepatocellular diffusion phenomena were derived as image forms in the Laplace domain, the fast inverse Laplace transform (FILT) was adopted to manipulate the image equations. Cefixime and cefpiramide were selected as model drugs. The concentrations in the perfusate and the excreted amounts into the bile were simultaneously measured at appropriate intervals after the rapid administration of each drug into the portal vein. The hepatocellular diffusion model was fitted to the biliary excretion profiles from rat livers, by means of a nonlinear least squares program, MULTI(FILT). According to this model, the hepatobiliary transport process of drug is kinetically separated into three steps, that is, the diffusion into and through the hepatocytes, the transfer from the hepatocytes into the bile canaliculi, and the movement through the bile canaliculi to the outlet of bile duct. These steps are characterized by the diffusion rate constant through hepatocytes (kdif), the permeability rate constant into the bile canaliculi (kbmc) and the transit time through the bile canaliculi to the outlet of bile duct (
Journal of Pharmacy and Pharmacology | 1996
Kenji Tabata; Kiyoshi Yamaoka; Hiroyuki Yasui; Takako Fukuyama; Terumichi Nakagawa
Journal of Pharmacy and Pharmacology | 1994
Hiroyuki Yasui; Kiyoshi Yamaoka; Masuhiro Nishimura; Shinsaku Naito; Terumichi Nakagawa
\bar t_{can}
Chemical & Pharmaceutical Bulletin | 1993
Takaki Koide; Hiromi Itoh; Akira Otaka; Hiroyuki Yasui; Masataka Kuroda; Nobuyoshi Esaki; Kenji Soda; Nobutaka Fujii
Journal of Pharmaceutical Sciences | 1996
Hiroyuki Yasui; Kiyoshi Yamaoka; Terumichi Nakagawa
), respectively. It was demonstrated that kdif of cefixime (0.023min1) was significantly smaller than that of cefpiramide (0.044 min1), while the differences in kbmc and
Biological & Pharmaceutical Bulletin | 1995
Masuhiro Nishimura; Kiyoshi Yamaoka; Hiroyuki Yasui; Shinsaku Naito; Terumichi Nakagawa
Journal of Pharmaceutical Sciences | 1995
Hiroyuki Yasui; Kiyoshi Yamaoka; Nobuhito Dote; Terumichi Nakagawa
\bar t_{can}
Biological & Pharmaceutical Bulletin | 1994
Masuhiro Nishimura; Kiyoshi Yamaoka; Hiroyuki Yasui; Shinsaku Naito; Terumichi Nakagawa
Journal of Pharmaceutical Sciences | 1994
Hiroyuki Yasui; Kiyoshi Yamaoka; Terumichi Nakagawa
were not obvious between cefixime and cefpiramide. kbmc and